Do fish oils prevent restenosis after coronary angioplasty?

Circulation

Volumn 90, Issue 5, 1994, Pages 2248-2257

  Leaf, Alexander ^a   Jorgensen, Michael B ^b   Jacobs, Alice K ^c   Cote, Gilles ^d   Schoenfeld, David A ^a   Scheer, Judy ^a   Weiner, Bonnie H ^e   Slack, John D ^f   Kellett, Mirle A ^g   Raizner, Albert E ^h   Weber, Peter C ⁱ   Mahrer, Peter R ^b   Rossouw, Jacques E ^j  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KAISER PERMANENTE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d MONTREAL HEART INSTITUTE   (Canada)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f Nasser   (United States)

^g MAINE MEDICAL CENTER   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

angioplasty; fatty acids; fish oil; restenosis

Indexed keywords

ALPHA TOCOPHEROL; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; GAMMA TOCOPHEROL; ICOSAPENTAENOIC ACID;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0028132168     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.5.2248     Document Type: Article

References (34)

1. Bang HO, Dyerberg J, Horne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976;200: 69-73.
2. Hirai A, Terano R, Saito H, et al. Eicosapentaenoic acid and platelet function in Japanese. In: Lovenburg W, Yamori Y, eds. Nutritional Prevention of Cardiovascular Disease. New York, NY: Academic Press; 1984:231-239.
3. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209.
4. Dolcek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Med. 1992;200: 177-182.
5. Davis HR, Bridenstine RT, Vesselinovitch D, Wissler RW. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Arteriosclerosis. 1987;7:441-449.
6. Parks JS, Kaduck-Sawyer B, Bullock C, Rudel LL. Effect of dietary fish oil on coronary artery and aortic atherosclerosis in African Green Monkeys. Atherosclerosis. 1990;10:1103-1112.
7. Weiner BH, Ockene IS, Levine PH, et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N EnglJ Med. 1986;315:841-846.
8. Kim DN, Ho HT, Lawrence DA, Schmee J, Thomas WA. Modification of lipoprotein patterns and retardation of atherogenesis by a fish oil supplement to a hyperlipidemic diet for swine. Atherosclerosis. 1989;76:35-54.
9. Leaf A. Health claims: omega-3 fatty acids and cardiovascular disease. Nutr Rev. 1992;50:150-154.
10. Block PC. Percutaneous transluminal coronary angioplasty: role in the treatment of coronary artery disease. Circulation. 1985; 72(suppl):161-165.
11. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988;12: 616-623.
12. The Cardiology Working Group. Cardiology and the quality of medical practice. JAMA. 1991;265:482-485.
13. Slack JD, Pinkerton CA, VanTassel J, Orr CM, Scott M, Allen B, Nasser WK. Can oral fish oil supplement minimize re-stenosis after percutaneous transluminal coronary angioplasty? J Am Coll Cardiol. 1987;9:64A.
14. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 1988;319:733-740.
15. Grigg LE, Kay TWH, Valentine PA, Larkins R, Flower DJ, Manolas EG, O'Dea K, Sinclair AJ, Jopper JL, Hunt D. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol. 1989;13:665-672.
16. Milner MR, Gallino RA, Leffingwell A, Descalzi-Prichard A, Brooks-Robinson S, Rosenberg J, Little T, Lindsay J. Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1989;64:294-299.
17. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Bairn DS, Sacks FM, Grossman W, Pasternak RC. Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989;2:177-181.
18. Nye ER, Ilsley CD, Ablett MB, Sutherland WHF, Robertson MC. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z Med. 1990;20:549-552.
19. Bairati I, Roy L, Meyer F. Double blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation, 1992;85:950-956.
20. Kaul U, Sanghvi S, Bahl VK, Dev V, Wasir HS. Fish oil supplements for prevention of restenosis after coronary angioplasty. Int J Cardiol. 1992;35:87-93.
21. Bellamy CM, Schofield PM, Faragher EB, Ramsdale DR. Can supplementation of diet with omega-3 polyunsaturated fatty acids reduce coronary angioplasty restenosis rate? Eur Heart J. 1992;13: 1626-1631.
22. O'Connor GT, Malenka DJ, Olmstead EM, Johnson PS, Hennekens CH. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med. 1992;8:186-192.
23. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty: a meta-analysis. Arch Intern Med. 1993;1595-1601.
24. Nutrition Committee, American Heart Association. Dietary guidelines for healthy American adults. Circulation. 1988;77:721A.
25. Williams DO, Gruentzig AR, Kent KM, Detre KM, Kelsey SF. To T. Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis. Am J Cardiol. 1984;53:32C.
26. The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA. 1989;320:618-627.
27. Friedwald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol without use of the ultracentrifuge. Clin Chem. 1972;18:449-502.
28. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
29. Lorenz RL, Uedelhoven WM, Fischer S, Rutzel A, Weber PC. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. BBA 1989;993:259-265.
30. Fischer S, Weber PC, Dyerberg J. The prostacyclin/thromboxane balance is favorably shifted in Greenland Eskimos. Prostaglandins. 1986:32:235-241.
31. Nordoy A, Barstad L, Connor WE, Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am J Clin Nut r. 1991;53:1185-1190.
32. Nordoy A, Hatcher L, Goodnight S, FitzGerald GA, Connor WE. Effects of dietary fat content, saturated fatty acids and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med. 1994;123:914-920.
33. Mueller HS, Cohen LS, Braunwald E, Forman S, and others. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase H. Circulation. 1992;85:1254-1264.
34. Zahgar D, Cercek B, Davis V, Mires A, Cannon CP, Shah PK, for the TIMI-4 Investigators. Is the outcome of thrombolysis in smokers better than that of non-smokers? A TIMI-4 related study. Circulation. 1993;88(suppl I):I-50. Abstract.